Maternally expressed gene 3 regulates retinal neovascularization in retinopathy of prematurity

Yu Di1, Yue Wang1, Yue-Xia Wang1

  • 1Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.

Insights

Maternally expressed gene 3 (MEG3) overexpression inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. This finding suggests MEG3 lentivirus could treat retinopathy of prematurity.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Oxygen-induced retinopathy (OIR) mouse model is crucial for studying retinal neovascularization diseases like retinopathy of prematurity.
  • Maternally expressed gene 3 (MEG3) shows inhibitory effects in diabetic retinopathy.

Purpose of the Study:

  • To investigate the role and mechanism of MEG3 overexpression in OIR mice.
  • To evaluate the potential of MEG3 lentivirus for treating retinopathy of prematurity.

Main Methods:

  • Establishing an oxygen-induced retinopathy mouse model.
  • Overexpressing MEG3 using lentivirus in OIR mice.
  • Analyzing the expression of key signaling molecules and inflammatory factors.

Main Results:

  • MEG3 overexpression significantly inhibited retinal neovascularization in OIR mice.
  • MEG3 down-regulated the expression of phosphoinositide 3-kinase, serine/threonine kinase, vascular endothelial growth factor, and pro-inflammatory factors.
  • MEG3 overexpression demonstrated therapeutic potential in the OIR model.

Conclusions:

  • MEG3 overexpression effectively suppresses retinal neovascularization in OIR by modulating specific molecular pathways.
  • MEG3 lentivirus represents a promising therapeutic strategy for retinopathy of prematurity.